Materials · Specialty Chemicals

Albemarle Corporation ALB

$113.16-3.02 (-2.60%)delayed quote · as of 2026-07-29 02:01 UTC

Open ALB in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$13.3B

Previous close

$116.18

Volume

2.3M

52-week range

$64.95 – $221.00

Verdictconfidence 81% · high

Health stands out; growth, quality and momentum flash caution.

1 of 5 dimensions score well; growth, quality and momentum flash caution. Value not scored — not enough data.

Value—1/2 checks

Growth251/4 checks

Quality402/5 checks

Health804/5 checks

Momentum201/5 checks

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

—

P/E FWD

9.0

EV/EBITDA TTM

29.8

PEG

—

FCF yield TTM

4.3%

Growth

Revenue 3y

−11.1%/yr

Revenue YoY

−4.4%

Expected EPS

—

Quality

Piotroski F

5 / 9

ROIC

-3.8%

Gross margin

13.0%

Health

Altman Z

2.01

Current ratio

2.23

Debt/equity

0.34

Momentum

vs 50-day

−33.8%

vs 200-day

−6.1%

52-wk range

31%

FY 2025: revenue $5.1B · net income -$510.6M · free cash flow $692.5M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-29 02:01 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading ALB’s filed statements…

Continue with ALB in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.